Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
0.3299
-0.0076 (-2.25%)
At close: Jun 6, 2025, 4:00 PM
0.3205
-0.0094 (-2.85%)
After-hours: Jun 6, 2025, 7:48 PM EDT
Aethlon Medical Employees
Aethlon Medical had 14 employees as of March 31, 2024. The number of employees decreased by 1 or -6.67% compared to the previous year.
Employees
14
Change (1Y)
-1
Growth (1Y)
-6.67%
Revenue / Employee
n/a
Profits / Employee
-$682,758
Market Cap
6.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
AEMD News
- 23 days ago - Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma - PRNewsWire
- 3 months ago - Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - PRNewsWire
- 4 months ago - Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025 - PRNewsWire
- 4 months ago - Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update - PRNewsWire
- 4 months ago - Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025 - PRNewsWire
- 4 months ago - Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial - PRNewsWire
- 6 months ago - Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu - PRNewsWire